N/A (American Regent, Inc.)


Welcome to the PulseAid listing for the N/A drug offered from American Regent, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: American Regent, Inc.
NON-PROPRIETARY NAME: busulfan
SUBSTANCE NAME: BUSULFAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-04-01
END MARKETING DATE: 0000-00-00


N/A HUMAN PRESCRIPTION DRUG Details:

Item DescriptionN/A from American Regent, Inc.
LABELER NAME: American Regent, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6(mg/mL)
START MARKETING DATE: 2017-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0517-0920_a4944e7c-0a07-4788-943a-6972a960a5d3
PRODUCT NDC: 0517-0920
APPLICATION NUMBER: ANDA202259

Other BUSULFAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.N/A
Aspen Global Inc.MYLERAN
Otsuka America Pharmaceutical, Inc.BUSULFEX
Pharmascience Inc.Busulfan
Sagent PharmaceuticalsBusulfan